XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements Of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 3,738.0 $ 3,933.9 $ 11,177.4 $ 11,562.5
Other revenues 13.2 8.0 33.8 27.1
Total revenues 3,751.2 3,941.9 11,211.2 11,589.6
Cost of sales 2,292.0 2,250.6 6,802.6 6,747.5
Gross profit 1,459.2 1,691.3 4,408.6 4,842.1
Operating expenses:        
Research and development 198.4 211.2 602.2 602.4
Acquired IPR&D 0.0 1.0 (1.7) 11.2
Selling, general and administrative 1,003.4 1,053.5 3,378.9 3,044.3
Litigation settlements and other contingencies, net 31.5 (26.1) 239.3 (36.5)
Total operating expenses 1,233.3 1,239.6 4,218.7 3,621.4
Earnings from operations 225.9 451.7 189.9 1,220.7
Interest expense 145.6 141.5 429.8 432.2
Other income, net (10.2) (92.0) (143.2) (269.4)
Earnings (loss) before income taxes 90.5 402.2 (96.7) 1,057.9
Income tax (benefit) provision (4.3) 70.6 21.0 237.6
Net earnings (loss) $ 94.8 $ 331.6 $ (117.7) $ 820.3
Earnings (loss) per share attributable to Viatris Inc. shareholders        
Basic (in USD per share) $ 0.08 $ 0.28 $ (0.10) $ 0.68
Diluted (in USD per share) $ 0.08 $ 0.27 $ (0.10) $ 0.68
Weighted average shares outstanding:        
Basic (in shares) 1,193.5 1,199.5 1,193.3 1,200.4
Diluted (in shares) 1,200.4 1,207.6 1,193.3 1,205.6